{"nct_id":"NCT00820222","title":"Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer","status":"COMPLETED","status_verified_date":"2019-03","start_date":"2009-04-14","start_date_type":"ACTUAL","primary_completion_date":"2012-06-11","primary_completion_date_type":"ACTUAL","completion_date":"2018-03-22","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}